The University of Oxford is part of a £15.9 million UK-wide programme to develop human tumour tissue models, improving cancer ...
With an AI-led platform for drug discovery and a growing global client base, Medvolt AI is emerging as one of India’s most ...
A superbug that does not respond to the very last ditch antibiotics and that has been circulating in Asia and Europe arrives ...
Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...
Microsoft launches MAI Superintelligence Team led by Mustafa Suleyman, focusing on “humanist” AI models for healthcare, ...
Wharton's Peter Cappelli shares eye-opening research on the impact of AI on a company's productivity and headcount.
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced that it has entered into a securities purchase agreement with a ...
In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the ...
Announces $6 Million Registered Direct Offering With Concurrent Private Placement Of Warrants. NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing broad-spectrum antiviral ...
At this year’s American Society of Human Genetics (ASHG) meeting, Ultima Genomics drew attention for its ambitious goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback